Netherlands
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.43 B
|
Dec. 31, 2023 | USD 36.38 | 0.42% |
|
Netherlands |
|
2 |
USD 445.25 M
|
Dec. 31, 2023 | USD 44.64 | 0.29% |
|
Netherlands |
|
3 |
USD -4.88 M
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
4 |
USD -19.09 M
|
Dec. 31, 2023 | USD 129.11 | 4.28% |
|
Netherlands |
|
5 |
USD -35.16 M
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
6 |
USD -43.25 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
7 |
USD -106.97 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
8 |
USD -126.93 M
|
Dec. 31, 2023 | USD 27.32 | 1.49% |
|
Netherlands |
|
9 |
USD -156.55 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
10 |
USD -165.73 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
11 |
USD -282.87 M
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
|
12 |
USD -425.05 M
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
The Healthcare company in Netherlands with the highest Operating Income is Koninklijke Ahold Delhaize N.V. (Amsterdam Stock Exchange: AD.AS) at USD 3.43 B.
The Healthcare company in Netherlands with the lowest Operating Income is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD -425.05 M.
The top 10 Healthcare companies in Netherlands by Operating Income are Koninklijke Ahold Delhaize N.V., Qiagen N.V., Pharming Group N.V., Redcare Pharmacy NV, ProQR Therapeutics N.V., LAVA Therapeutics N.V., Pharvaris N.V., Koninklijke Philips N.V., Merus N.V. and NewAmsterdam Pharma Company N.V..
The bottom 10 Healthcare companies in Netherlands by Operating Income are argenx SE, uniQure N.V., NewAmsterdam Pharma Company N.V., Merus N.V., Koninklijke Philips N.V., Pharvaris N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Redcare Pharmacy NV and Pharming Group N.V..